In the US, Sodium Oxybate (sodium oxybate systemic) is a member of the drug class miscellaneous anxiolytics, sedatives and hypnotics and is used to treat Cataplexy, Fibromyalgia and Narcolepsy.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Butanoic acid, 4-hydroxy-, monosodium salt
- Natrii oxybas (Latin)
- Natrium 4-hydroxybutyrat (German)
- Sodium, oxybate de (French)
- Oxibato de sodio (Spanish)
- Sodium Oxybate (OS: USAN)
- Gam-OH (IS)
- NSC-84223 (IS)
- Wy 3478 (IS: Wyeth)
SERB Laboratoires, France
- Natrii oxybutyras Kalceks
Jazz Pharmaceuticals, United States; UCB, Czech Republic; UCB, Denmark; UCB, Finland; UCB, Lithuania; UCB, Netherlands; UCB, Norway; UCB, Poland; UCB, Portugal; UCB, Romania; UCB, Slovakia; UCB Nordic, Sweden; UCB Pharma, Austria; UCB Pharma, Belgium; UCB Pharma, Germany; UCB Pharma, Spain; UCB Pharma, France; UCB Pharma, United Kingdom; UCB Pharma, Italy; UCB-Pharma, Switzerland; Valeant Pharmaceuticals International, Canada
|USAN||United States Adopted Name|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.